NASDAQ: OBIO - Orchestra BioMed Holdings, Inc.

छह महीने के लिए लाभप्रदता: -17.07%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Orchestra BioMed Holdings, Inc.


कंपनी के बारे में Orchestra BioMed Holdings, Inc.

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension; and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold retractors that are minimally invasive surgical device solutions.

अधिक जानकारी
The company has a strategic collaboration with Medtronic for the development and commercialization of BackBeat CNT for the treatment of hypertension in pacemaker-indicated patients; and a strategic partnership with Terumo Corporation for the development and commercialization of Virtue SAB for the treatment of artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

IPO date 2020-08-04
ISIN US68572M1062
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://orchestrabiomed.com
Цена ао 3.84
प्रति दिन मूल्य परिवर्तन: +6.25% (3.84)
प्रति सप्ताह मूल्य परिवर्तन: -3.55% (4.23)
प्रति माह मूल्य परिवर्तन: -23.45% (5.33)
3 महीने में कीमत में बदलाव: -22.43% (5.26)
छह महीने में कीमत में बदलाव: -17.07% (4.92)
प्रति वर्ष मूल्य परिवर्तन: -23.31% (5.32)
3 वर्षों में मूल्य परिवर्तन: -58.75% (9.89)
5 वर्षों में मूल्य परिवर्तन: 0% (4.08)
10 वर्षों में मूल्य परिवर्तन: 0% (4.08)
वर्ष की शुरुआत से मूल्य परिवर्तन: -17.07% (4.92)

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 119.06 1
P/BV 4.83 3
P/E 0 0
EV/EBITDA -5.85 0
कुल: 2.88

क्षमता

नाम अर्थ श्रेणी
ROA, % -51.59 0
ROE, % -72.19 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.0329 10
कुल: 9.8

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % -51.58 0
लाभप्रदता Ebitda, % 175.37 10
लाभप्रदता EPS, % 118.86 10
कुल: 7.6

संस्थानों आयतन शेयर करना, %
RTW Investments LP 5620640 15.71
Perceptive Advisors LLC 2432089 6.8
Blackrock Inc. 1468768 4.11
Vanguard Group Inc 1227282 3.43
Price (T.Rowe) Associates Inc 622608 1.74
Geode Capital Management, LLC 425749 1.19
State Street Corporation 285910 0.8
Boxer Capital, LLC 238193 0.67
Charles Schwab Investment Management, Inc. 175545 0.49
Northern Trust Corporation 142879 0.4

ETF शेयर करना, % वर्ष के लिए लाभप्रदता, % लाभांश, %
iShares Micro-Cap ETF 0.02967 17.09 1.54048
Vanguard Russell 2000 ETF 0.01 17.16 1.48801
iShares Russell 2000 Growth ETF 0.00387 38.04 0.6026
Schwab U.S. Small-Cap ETF 0.00339 17.47 1.51433
ProShares UltraPro Russell2000 0.00248 89.82 1.47873
Avantis U.S Small Cap Equity ETF 0.00162 27.77 1.68271
ProShares Hedge Replication ETF 0.00069 5.92 1.47892
Schwab U.S. Broad Market ETF 0.00032 24.86 1.43354
Vanguard Russell 2000 Growth ETF 0 23.05 0.60264
Vanguard Russell 3000 ETF 0 31.87 1.43817



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. David P. Hochman Founder, Chairman of the Board of Directors & CEO 942k 1975 (50 साल)
Mr. Darren R. Sherman Founder, President, COO & Director 787k 1971 (54 वर्ष)
Mr. Andrew Lawrence Taylor M.B.A. Chief Financial Officer 500.02k 1971 (54 वर्ष)
Mr. William Reed Little Executive Vice President of Corporate Development & Strategy N/A 1971 (54 वर्ष)
Dr. Yuval Hay Mika D.Sc, Ph.D. GM & CTO of Bioelectronic Therapies N/A 1959 (66 साल)
Dr. George Papandreou Ph.D. GM & Senior VP of Focal Therapies N/A 1965 (60 साल)
Dr. Hans-Peter Stoll M.D., Ph.D. Chief Clinical Officer N/A
Dr. Avraham Matityahu Fischer M.D. Senior Vice President of Medical Affairs & Innovation N/A 1956 (69 साल)
Mr. Bob Laughner Senior Vice President of Regulatory & Quality N/A
Mr. Juan Lorenzo Senior Vice President of Product Development N/A

पता: United States, New Hope. PA, 150 Union Square Drive - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://orchestrabiomed.com